Hospital compliance officers, CISOs, and administrators evaluating whether AI is safe to deploy with patient data will find direct answers here. This FAQ covers data privacy, security safeguards, and regulatory alignment for AI used in Indian healthcare settings, including ABDM and India's Digital Personal Data Protection (DPDP) Act.
1. Is it safe to use AI systems that handle patient data in India?
Yes, it is safe to use AI systems that handle patient data in India provided the vendor follows strict data security practices — encryption in transit and at rest, access controls, and clear data retention policies — and the hospital retains oversight of what data is shared and how it is used. Patient data is sensitive by nature, and any AI vendor handling it should be able to clearly explain where data is stored, who can access it, and how long it is retained. Hospitals should treat this evaluation the same way they would evaluate any third-party system handling patient information, asking for the vendor's security certifications and data handling documentation before deployment. A reputable AI vendor will welcome this scrutiny rather than treat it as a hurdle.
2. Does India have a law equivalent to HIPAA for healthcare data, and does AI need to comply with it?
India does not have a healthcare-specific law identical to the US HIPAA framework, but the Digital Personal Data Protection (DPDP) Act governs the processing of personal data, including health data, and applies to AI systems handling patient information. Under the DPDP Act, entities processing personal data — including hospitals and their AI vendors — have obligations around consent, purpose limitation, and data security. Healthcare data is widely treated as sensitive personal data requiring heightened care in how it is collected, stored, and used, even where not always explicitly categorized with special provisions under current law. Hospitals should ensure any AI vendor's data practices are structured to align with DPDP principles — clear consent, defined purpose, and limited retention — as a baseline.
3. How does AI in healthcare align with the Ayushman Bharat Digital Mission (ABDM)?
AI in healthcare aligns with ABDM by supporting the structured digital health record standards the mission promotes, and by working within the consent-based data sharing framework ABDM establishes for health information exchange. ABDM's architecture is built around patient consent for sharing health records between providers, and AI systems that touch patient records — for scheduling, follow-up, or claims — should respect this same consent-first approach rather than operating as a separate, disconnected data silo. Hospitals adopting ABDM's Unique Health ID and interoperability standards should evaluate whether their AI vendor can work within or alongside this framework, particularly for use cases involving discharge summaries or health records that may eventually need to interoperate with ABDM-linked systems.
4. What happens to patient voice recordings and call transcripts collected by AI systems?
Patient voice recordings and call transcripts should be stored securely, retained only as long as necessary for the stated purpose, and accessible only to authorized personnel — hospitals should require this in writing from any AI vendor. Voice interactions often contain sensitive information beyond the immediate query, such as mentions of medical conditions or family circumstances, which makes secure handling especially important. A hospital should ask its AI vendor exactly how long recordings and transcripts are retained, whether they are used to improve the AI model and under what consent basis, and how a patient's request to delete their data would be handled. These answers should be documented in the vendor contract, not left as informal assurances.
5. Can AI systems be configured to keep patient data within India?
Yes, AI systems can and generally should be configured for data residency within India when handling patient information, and hospitals should confirm this explicitly with any vendor before deployment. Data residency matters both for regulatory alignment and for the practical reality that Indian healthcare data governance expectations are moving toward stricter localization over time. A hospital should ask where servers processing and storing patient data are physically located, and should treat vendors unable to confirm India-based data residency as a compliance risk for sensitive health data. This is a reasonable and increasingly standard requirement to include in vendor evaluation criteria.
6. How is patient consent handled when AI contacts patients for reminders or follow-up calls?
Patient consent for AI-driven reminder and follow-up calls should be established at the point of patient registration or appointment booking, with clear disclosure that automated systems may be used for such communication. Hospitals should ensure patients are informed — typically through registration forms or verbal disclosure — that they may receive automated calls or messages for appointment reminders, follow-up check-ins, or billing notifications. Patients should also have a straightforward way to opt out of automated communication if they prefer human-only contact. Building this consent capture into existing registration workflows, rather than treating it as a separate compliance exercise, makes it easier to maintain consistently across a hospital's patient base.
7. What security certifications or standards should a healthcare AI vendor have?
A healthcare AI vendor should be able to demonstrate strong information security practices, ideally aligned with recognized standards such as ISO 27001 for information security management, along with clear data encryption, access control, and audit logging capabilities. While there is no single mandatory certification specific to healthcare AI vendors in India, hospitals evaluating vendors should ask for documentation of their security posture, including how they handle data breaches, how frequently they conduct security audits, and what access controls exist internally within the vendor's own team. NABH-accredited hospitals, which already operate under strict quality and safety documentation standards, should extend similar scrutiny to their technology vendors handling patient data.
8. Can AI accidentally expose sensitive patient information, and how is this risk managed?
AI can pose a data exposure risk if not properly configured, most commonly through overly broad access permissions, unsecured data transmission, or inadequate separation between different hospital departments' data. This risk is managed through role-based access controls that limit what data an AI system can retrieve for a given interaction, encryption of data in transit and at rest, and regular security testing of the integration points between the AI and the hospital's core systems. Hospitals should insist on the principle of least privilege — the AI should only access the specific data fields needed for its defined use case, not blanket access to the full patient record. Clear audit logs of what data was accessed and when also allow a hospital to investigate quickly if an issue is suspected.
9. Who is responsible if patient data is mishandled by an AI vendor — the hospital or the vendor?
Responsibility for patient data mishandling is typically shared between the hospital and the AI vendor, governed by the terms of their contract, but the hospital as the data controller generally retains ultimate accountability to the patient and regulators. This makes it essential for hospitals to negotiate clear data processing agreements with AI vendors that specify each party's obligations, breach notification timelines, and liability terms. A hospital should not assume that outsourcing a function to an AI vendor also outsources its compliance responsibility — regulators and patients will typically look first to the hospital as the entity that collected the data. Strong contractual terms and regular vendor audits are the practical tools hospitals have to manage this shared responsibility.
10. How should a hospital evaluate an AI vendor's data privacy practices before signing a contract?
A hospital should evaluate an AI vendor's data privacy practices by reviewing their data storage location, retention policies, encryption standards, access controls, sub-processor arrangements, and breach notification procedures, ideally through a formal security questionnaire and a data processing agreement. It's reasonable to ask for a walkthrough of exactly how patient data flows through the vendor's system, from the moment a call or document is received to where it is ultimately stored and eventually deleted. Hospitals should also check whether the vendor has previously worked with other NABH-accredited hospitals or Indian healthcare providers, since prior healthcare-specific experience often correlates with more mature data handling practices. This evaluation should be treated as a standard part of vendor onboarding, not an afterthought completed after the contract is signed.
Related Reading
Related reading
Talk to YuVerse
To understand how YuVerse handles data residency, consent, and security for patient-facing AI, talk to our team at https://yuverse.ai/contact?utm_source=qa-hub.